NASDAQ •
Healthcare •
Medical Devices •
Quote as of 09/11/2026
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,935.36 mln
Float42.81 mln
Earnings Date11/05/2026
1-Year Forecast
33.40
Attractive
Relative Strength
9
/ 100
Severely lagging
Debt / Equity
0.16
Very low leverage
Pre-Tax Margin
-39%
Deeply loss-making
ROA
-20.60
Deeply negative
Business Description
Alamar Biosciences, founded in 2018 and headquartered in Fremont, California, makes tools that help scientists detect and measure proteins in the blood to identify diseases at an early stage. Its flagship ARGO system automates this process with exceptional sensitivity, supporting research across fields such as cancer, neurology, and immunology. The company serves universities, drug developers, and research labs across North America, Europe, the Middle East, and Asia Pacific.
